Clinical trial
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
NCT00156533 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00156533 |
|---|---|
| Title | Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing |
| Official title | Long Term Treatment With Zolpidem: The Relative Efficacy of Nightly (Quaque Hora Somni [QHS]) & Intermittent Dosing and the Potential for Long Term Clinical Gains After Treatment Discontinuation. |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Sanofi-Synthelabo Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia, Primary Insomnia, Psychophysiologic Insomnia |
| Intervention type | Drug |
| Interventions | Zolpidem, Sugar Pill |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 20, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: